my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
02-08-2012: Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc.. This action was required under the consent order issued by the Federal Trade Commission (FTC) as part of the acquisition of Dermik, a dermatology unit of Sanofi, which was completed in December 2011.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc.. This action was required un ... more
Valeant Pharmaceuticals Acquires Probiotica in Brazil
Valeant Pharmaceuticals International, Inc. announced that Valeant has acquired Probiotica Laboratorios Ltda. Probiotica currently markets a full line of over-the-counter sports nutrition products and other food supplements, with a 30 percent share of the market. Valeant will acquire Probio ... more
Valeant Pharmaceuticals Agrees to Acquire iNova
Valeant Pharmaceuticals International, Inc. announced that it has signed an agreement to acquire iNova, a private pharmaceutical group which sells and distributes a range of prescription and over-the-counter (OTC) products in Australia, New Zealand, Southeast Asia and South Africa from Arch ... more
Valeant Pharmaceuticals International
Valeant Pharmaceuticals International is a global specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, infectious disease and dermatology. more
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc.. This action was required un ... more
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex
Mylan Inc. announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bicalutamide Tablets, 50 mg. Bicalutamide Tablets are the generic version of AstraZeneca's prostate ... more
UCB's Keppra patent litigation in the US settled
UCB announced that it has reached agreement with each of Mylan Laboratories and Mylan Pharmaceuticals, Dr. Reddy's Laboratories and Cobalt Pharmaceuticals to settle pending patent infringement lawsuits in the U.S. District Court for the Northern District of Georgia. These consolidated laws ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
